Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.43 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.43 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.43 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.43 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.40 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 2/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.37 |
| ▸ | MEP1B | Q16820 | 1/20 | 0.36 |
| ▸ | ERN1 | O75460 | 2/20 | 0.36 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.36 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.36 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.36 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
| ▸ | VRK1 | Q99986 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lithium SCHEMBL31361451 | 0.97 | CYP3A4 (0.48) | CYP3A4TSHRTDP1GABRA1GABRB1 | |
| Bromide SCHEMBL4668136 | 0.97 | CYP3A4 (0.48) | CYP3A4TSHRTDP1GABRA1GABRB1 | |
| Potassium SCHEMBL31361438 | 0.97 | CYP3A4 (0.48) | CYP3A4TSHRTDP1GABRA1GABRB1 | |
| SCHEMBL31361467 | 0.97 | CYP3A4 (0.48) | CYP3A4TSHRTDP1GABRA1GABRB1 | |
| SCHEMBL2050124 | 0.88 | CYP3A4 (0.46) | CYP3A4TSHRTDP1GABRA1GABRB1 | |
| SCHEMBL11744136 | 0.86 | CYP3A4 (0.65) | CYP3A4TSHRTDP1GABRA1GABRB1 | |
| SCHEMBL528819 | 0.82 | TSHR (0.40) | CYP3A4TSHRTDP1GABRA1GABRB1 | |
| SCHEMBL2245908 | 0.82 | CYP3A4 (0.40) | CYP3A4TSHRTDP1GABRA1GABRB1 | |
| SCHEMBL31253165 | 0.82 | CYP3A4 (0.40) | CYP3A4TSHRTDP1GABRA1GABRB1 | |
| SCHEMBL30467799 | 0.82 | TTR (0.40) | CYP3A4TSHRTDP1GABRA1GABRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 614 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119039115-A | Preparation method of 2, 6-difluoro-4-bromotrifluoromethoxybenzene | 大连奇凯医药科技有限公司 | 2024-11-29 | — | — | CN | claimed |
| CN-111574334-B | Novel phenolic compound and preparation method and application thereof | 江汉大学 | 2023-02-10 | — | — | CN | claimed |
| CN-111574334-A | Novel phenolic compound and preparation method and application thereof | 江汉大学 | 2020-08-25 | — | — | CN | claimed |
| CN-104761437-A | Preparation method of 4-bromo-2, 6-difluorotrifluoromethoxybenzene | SHANGHAI CHEMSPEC INTERNAT LTD | 2015-07-08 | — | — | CN | claimed |
| JP-3501455-B2 | — | — | 2004-03-02 | — | — | JP | claimed |
| WO-1993003113-A1 | LIQUID-CRYSTAL COMPOUNDS | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1993-02-18 | — | — | WO | claimed |
| EP-0276558-A2 | Insecticidal ethers | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1988-08-03 | — | — | EP | claimed |
| US-20260137680-A1 | NOVEL COMPOUNDS | SITRYX THERAPEUTICS LTD (GB) | 2026-05-21 | — | — | US | disclosed |
| US-20260078117-A1 | COMPOUNDS AND METHODS OF USE | TANGO THERAPEUTICS INC (US) | 2026-03-19 | — | — | US | disclosed |
| US-20260049092-A1 | ANTIBACTERIAL COMPOUNDS | BLACKSMITH MEDICINES INC (US) | 2026-02-19 | — | — | US | disclosed |
| US-20250326766-A1 | RIPK1 INHIBITORS AND METHODS OF USE | MERCK SHARP & DOHME LLC (US) | 2025-10-23 | — | — | US | disclosed |
| US-20250320228-A1 | PYRIDO[3,2-D]PYRIMIDINES AS HPK1 INHIBITORS | MERCK PATENT GMBH (DE) | 2025-10-16 | — | — | US | disclosed |
| EP-4568955-A1 | ANTIBACTERIAL COMPOUNDS | Blacksmith Medicines, Inc. (US) | 2025-06-18 | — | — | EP | disclosed |
| US-4791139-A | Diphenyl ether derivatives and their use as insecticides | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1988-12-13 | — | — | US | disclosed |
| CN-88100088-A | Parasiticidal ether compound | — | 1988-10-05 | — | — | CN | disclosed |
| EP-0276558-A2 | Insecticidal ethers | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1988-08-03 | — | — | EP | disclosed |
| US-4750931-A | GRASSY WEEDS | THE DOW CHEMICAL COMPANY (US) | 1988-06-14 | — | — | US | disclosed |
| CN-87102455-A | Diphenyl ether derivatives pesticide compound | — | 1988-01-27 | — | — | CN | disclosed |
| EP-0240121-A2 | Diphenyl ether derivatives | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1987-10-07 | — | — | EP | disclosed |
| EP-0142328-A2 | Fluorophenoxy compounds, herbicidal compositions and methods | THE DOW CHEMICAL COMPANY (US) | 1985-05-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260137680-A1 | NOVEL COMPOUNDS | CCR1, CCR4, CCR3 | CYP3A4 219/4885TSHR 3430/4885TDP1 2040/4885 |
| US-20250320228-A1 | PYRIDO[3,2-D]PYRIMIDINES AS HPK1 INHIBITORS | PDXK, PPIP5K2, IP6K1 | CYP3A4 1890/4885TSHR 3727/4885TDP1 350/4885 |
| US-20260049092-A1 | ANTIBACTERIAL COMPOUNDS | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CBR1, FPR1 | CYP3A4 1632/4885TSHR 1023/4885TDP1 4409/4885 |
| US-20250326766-A1 | RIPK1 INHIBITORS AND METHODS OF USE | RIPK1, RIPK2, RIPK3 | CYP3A4 4805/4885TSHR 4246/4885TDP1 647/4885 |
| US-20260078117-A1 | COMPOUNDS AND METHODS OF USE | NR3C2, ADRA1A, CNR1 | CYP3A4 706/4885TSHR 246/4885TDP1 3504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.